Impact of Acute Ischemic Stroke Treatment in Patients >80 Years of Age
Author(s) -
Joshua Z. Willey,
Santiago OrtegaGutiérrez,
Nils Petersen,
Pooja Khatri,
Andria L. Ford,
Natalia S. Rost,
Latisha K. Ali,
Nichole R. Gonzales,
José G. Merino,
Brett C. Meyer,
Randolph S. Marshall
Publication year - 2012
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.112.660993
Subject(s) - medicine , ischemic stroke , stroke (engine) , acute stroke , pediatrics , cardiology , emergency medicine , ischemia , tissue plasminogen activator , mechanical engineering , engineering
Few studies have addressed outcomes among patients ≥80 years treated with acute stroke therapy. In this study, we outline in-hospital outcomes in (1) patients ≥80 years compared with their younger counterparts; and (2) those over >80 years receiving intra-arterial therapy (IAT) compared with those treated with intravenous recombinant tissue-type plasminogen activator (IV rtPA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom